CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.
Completed
- Conditions
- Asthma
- Registration Number
- NCT00714038
- Lead Sponsor
- AstraZeneca
- Brief Summary
Quality Improvement in Primary Care: delegation of check-ups to nurses in general practice
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2122
Inclusion Criteria
- diagnosed with asthma
Exclusion Criteria
- patients with copd
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Lung function, improvements in lung function over time, patient compliance with treatment baseline, when necessary and at 1 year control
- Secondary Outcome Measures
Name Time Method Number of visits per patient, drop-out rate annually
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does nurse-led asthma check-up delegation affect airway inflammation biomarkers like IL-4/IL-13 in primary care?
What is the comparative effectiveness of nurse-managed vs. physician-led asthma care in reducing exacerbation frequency?
Which biomarkers correlate with improved FEV1 outcomes in nurse-delegated asthma secondary prevention programs?
What adverse event management strategies are implemented in nurse-led asthma care observational studies?
How does AstraZeneca's nurse delegation model compare to biologic therapies like omalizumab in asthma treatment optimization?
Trial Locations
- Locations (1)
Research Site
🇩🇰Vojens, Denmark